These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31744006)

  • 21. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
    Li X; Song D; Leng SX
    Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
    Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
    Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer's Disease in transgenic mice.
    Craig A; Parvez F; Issberner J
    Behav Brain Res; 2019 Oct; 372():112015. PubMed ID: 31255671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Aβ production prompts the onset of glucose intolerance and insulin resistance.
    Jiménez-Palomares M; Ramos-Rodríguez JJ; López-Acosta JF; Pacheco-Herrero M; Lechuga-Sancho AM; Perdomo G; García-Alloza M; Cózar-Castellano I
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1373-80. PubMed ID: 22414803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic hyperinsulinemia contributes to insulin resistance under dietary restriction in association with altered lipid metabolism in Zucker diabetic fatty rats.
    Morita I; Tanimoto K; Akiyama N; Naya N; Fujieda K; Iwasaki T; Yukioka H
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E264-E272. PubMed ID: 28143857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late life insulin resistance and Alzheimer's disease and dementia: The Kuakini Honolulu heart program.
    Lee TH; Hurwitz EL; Cooney RV; Wu YY; Wang CY; Masaki K; Grandinetti A
    J Neurol Sci; 2019 Aug; 403():133-138. PubMed ID: 31284182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alzheimer's disease and diabetes - the common pathogenesis].
    Halmos T; Suba I
    Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperinsulinemia and risk of Alzheimer disease.
    Luchsinger JA; Tang MX; Shea S; Mayeux R
    Neurology; 2004 Oct; 63(7):1187-92. PubMed ID: 15477536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling.
    Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE
    Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dementia and diabetes: casual or causal relationship?].
    Formiga F; Reñe R; Pérez-Maraver M
    Med Clin (Barc); 2015 Feb; 144(4):176-80. PubMed ID: 24629693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PP2Cα aggravates neuronal insulin resistance leading to AD-like phenotype in vitro.
    Yadav Y; Dey CS
    Biochem Biophys Res Commun; 2023 Feb; 644():49-54. PubMed ID: 36630734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis.
    Rasgon N; Jarvik L
    J Gerontol A Biol Sci Med Sci; 2004 Feb; 59(2):178-83; discussion 184-92. PubMed ID: 14999034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperinsulinaemia and Alzheimer's disease.
    Razay G; Wilcock GK
    Age Ageing; 1994 Sep; 23(5):396-9. PubMed ID: 7825486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance and hyperinsulinemia in hypertension.
    Weidmann P; Böhlen L; de Courten M
    J Hypertens Suppl; 1995 Aug; 13(2):S65-72. PubMed ID: 8576790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of parental history of type 2 diabetes on hyperinsulinemia and insulin resistance in subjects from central Mexico.
    Acevedo-Negrete AP; Porchia LM; Gonzalez-Mejia ME; Torres-Rasgado E; Solis-Cano DG; Ruiz-Vivanco G; Pérez-Fuentes R
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S895-S900. PubMed ID: 28697997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.